1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in Spain, July 2020

Mental Health Analysis & Statistics in Spain, July 2020

1-30 of about 100 reports

Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030

  • $ 3750
  • Jul 2020
  • 80 pages

‘Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Diabetic Peripheral Neuropathy ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Spain
  • United States

Treatment-resistant depression (TRD) - Epidemiology Forecast - 2030

  • $ 3750
  • June 2020
  • 100 pages

‘Treatment-resistant depression (TRD)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Treatment-resistant depression, historical and forecasted epidemiology in the ...

  • Depression
  • Mental Health
  • Pathology
  • Therapy
  • Spain

Pompe Disease - Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Pompe Disease (PD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pompe Disease in the United States, EU5 (Germany, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Spain
  • United Kingdom

Frontotemporal Dementia (FTD)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Frontotemporal Dementia (FTD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Frontotemporal Dementia in the United ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Spain
  • United States

Postpartum Depression - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Postpartum Depression (PPD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Postpartum Depression (PPD) epidemiology in the United ...

  • Depression
  • Mental Health
  • Germany
  • Spain
  • Forecast

Duchenne Muscular Dystrophy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Duchenne Muscular Dystrophy (DMD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Duchenne Muscular Dystrophy (DMD) epidemiology ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Spain
  • United States

Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 83 pages

Overview ‘Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Adrenoleukodystrophy epidemiology in the 7MM, ...

  • Mental Health
  • Neurological Disorder
  • Japan
  • Spain
  • United States

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 - Pipeline Review, H1 2020

  • $ 3500
  • March 2020
  • 41 pages

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 - Pipeline Review, H1 2020 Summary Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) - Gamma-aminobutyric acid ...

  • Dementia
  • Mental Health
  • Spain
  • Product Initiative
  • AGENEBIO INC.

Spain Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others.

  • $ 5995
  • January 2020
  • 175 pages

Spain Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. Summary new report, Spain Neurology Devices Market Outlook ...

  • Mental Health
  • Spain
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Stryker Corporation

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 41 pages

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 - Pipeline Review, H2 2019 Summary Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) - Gamma-aminobutyric acid ...

  • Dementia
  • Mental Health
  • Spain
  • Product Initiative
  • AGENEBIO INC.

Multiple Sclerosis: Epidemiology Forecast to 2028

  • $ 3995
  • November 2019
  • 38 pages

Multiple Sclerosis: Epidemiology Forecast to 2028 Summary Multiple sclerosis (MS) is an autoimmune disease affecting principally the central nervous system that causes nerve sheath demyelination followed ...

  • Health Services
  • Mental Health
  • Italy
  • Spain
  • Forecast

Embolotherapy Market

  • $ 4900
  • September 2019
  • 336 pages

Embolotherapy Market Research Report: By Product (Embolic Agents, Support Devices), Procedure (Transcatheter Arterial Embolization, Transarterial Radioembolization/Selective Internal Radiation Therapy, ...

  • Mental Health
  • Pathology
  • France
  • Spain
  • Demand

Latuda

  • $ 10000
  • March 2019
  • 39 pages

Latuda (lurasidone; Sumitomo Dainippon/Angelini) contains the atypical antipsychotic lurasidone, which acts as an antagonist of dopamine receptors D2, and serotonin receptors 5-HT2A. By inhibiting the ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Japan
  • Spain

University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • December 2018
  • 27 pages

Summary University of Barcelona is an educational university that offers bachelor’s degrees, master’s degrees and research doctoral studies.The university provides EHEA bachelor’s degree courses, ...

  • Healthcare
  • Mental Health
  • Pharmaceutical
  • Spain
  • Deals & Alliance

Spain Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • November 2018
  • 158 pages

Spain Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others Summary GlobalData’s new report, Spain Neurology Devices ...

  • Mental Health
  • Spain
  • B. Braun Melsungen AG
  • Medtronic, Inc.
  • Stryker Corporation

Oryzon Genomics SA (ORY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 66 pages

Summary Oryzon Genomics SA (Oryzon) is a clinical stage biopharmaceutical company that offers discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases.The company offers ...

  • Medical Biotechnology
  • Mental Health
  • Spain
  • Company
  • Oryzon Genomics S.A.

Parkinson’s Disease: Epidemiology Forecast to 2026

  • $ 3995
  • May 2018
  • 29 pages

Parkinson’s Disease: Epidemiology Forecast to 2026 Summary Parkinson’s disease (PD) is the second most common chronic progressive neurodegenerative disorder in the elderly after Alzheimer’s disease, ...

  • Mental Health
  • Psychotic Disorder
  • Spain
  • United States
  • Forecast

Drug Overview: Latuda

  • $ 10000
  • April 2018
  • 33 pages

Drug Overview  Latuda (lurasidone; Sumitomo Dainippon/Angelini) contains the atypical antipsychotic lurasidone, which acts as an antagonist of dopamine receptors D2, and serotonin receptors 5-HT2A. ...

  • Mental Health
  • Psychotic Disorder
  • Japan
  • Spain
  • Supply

EPIOMIC EPIDEMIOLOGY SERIES: EPILEPSY FORECAST IN 19 MAJOR MARKETS 2018–2028

  • $ 5577
  • April 2018
  • 86 pages

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Epilepsy in 19 Major Markets Epilepsy is a complex neurologic disorder characterised by the occurrence of seizures, divided into several types ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • Spain

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

  • $ 3995
  • October 2017
  • 37 pages

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026 Summary Alzheimer’s disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, ...

  • Dementia
  • Mental Health
  • Pathology
  • Spain
  • Forecast

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Depression
  • Mental Health
  • Pathology
  • Spain
  • Forecast

Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Schizophrenia patients study in a new report ‘Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Schizophrenia ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Spain
  • Forecast

Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Europe Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Europe
  • Spain

Europe Panic Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Panic Disorder patients study in a new report ‘Europe Panic Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Panic ...

  • Anxiety Disorder
  • Mental Health
  • Pathology
  • Spain
  • Forecast

Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Obsessive Compulsive Disorder patients study in a new report ‘Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017’. The report ...

  • Mental Health
  • Pathology
  • Personality Disorder
  • Europe
  • Spain

Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Spain
  • Forecast

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Major Depression patients study in a new report ‘Europe Major Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Depression
  • Mental Health
  • Pathology
  • Spain
  • Forecast

Europe Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Huntington’s Disease patients study in a new report ‘Europe Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Dementia
  • Mental Health
  • Pathology
  • Europe
  • Spain

Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Gaucher's Disease patients study in a new report ‘Europe Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Europe
  • Spain

Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Spain
  • Forecast

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on